Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
Conditions: Cutaneous T Cell Lymphoma; Mycosis Fungoides Interventions: Drug: Mogamulizumab; Drug: Brentuximab vedotin Sponsors: University of Alabama at Birmingham; Seagen Inc.; Kyowa Kirin Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials